| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 03, 2025 | Jun 04, 2025 | Klassen Preston Pres Head of R D | Buy | Regulus Therapeutics Inc. | RGLS | $7.99 | $95,852 | +19.98% |
| Jan 13, 2025 | Jan 15, 2025 | Klassen Preston Pres Head of R D | Sell | Regulus Therapeutics Inc. | RGLS | $1.26 | $39,721 | -46.59% |
| Jan 26, 2023 | Jan 27, 2023 | Klassen Preston Pres CEO | Sell | Metacrine, Inc. | MTCR | $0.41 | $157,266 | -41.26% |
| Apr 19, 2022 | Apr 20, 2022 | Klassen Preston Pres CEO | Sell | Metacrine, Inc. | MTCR | $0.5 | $22,472 | -4.63% |
| May 20, 2021 | May 20, 2021 | Klassen Preston Pres CEO | Buy | Metacrine, Inc. | MTCR | $3.64 | $74,692 | +50.00% |
| Jan 07, 2019 | Jan 09, 2019 | Klassen Preston EVP CMO | Sell | Arena Pharmaceuticals Inc | ARNA | $42.06 | $799,066 | -0 |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.